Pathophysiological aspects of Wnt-signaling in endocrine disease

European Journal of Endocrinology

Volumn 160, Issue 5, 2009, Pages 731-737

  Schinner, Sven ^a   Willenberg, Holger S ^a   Schott, Matthias ^a   Scherbaum, Werner A ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; APC PROTEIN; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON LIKE PEPTIDE 1; GLUCOKINASE; HYDROCORTISONE; PROGLUCAGON; PROTEIN KINASE B; TRANSCRIPTION FACTOR 7 LIKE 2; WNT PROTEIN;

ADIPOCYTE; ADRENAL CORTEX CARCINOMA; ALDOSTERONE RELEASE; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CELL SECRETION; ENDOCRINE CELL; ENDOCRINE DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HUMAN; HYDROCORTISONE RELEASE; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TARGET CELL; ANIMAL; BIOLOGICAL MODEL; GENETICS; MEDICAL GENETICS; PHYSIOLOGY;

ADIPOCYTES; ANIMALS; DIABETES MELLITUS, TYPE 2; ENDOCRINE SYSTEM DISEASES; GENETICS, MEDICAL; HUMANS; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 65549166298     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0831     Document Type: Review

References (53)

1. Gordon MD & Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. Journal of Biological Chemistry 2006 281 22429-22433.
2. Logan CY & Nusse R. The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004 20 781-810.
3. Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS & MacDougald OA. Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. Journal of Biological Chemistry 2002 277 38239-38244.
4. MacDougald OA & Mandrup S. Adipogenesis: forces that tip the scales. Trends in Endocrinology and Metabolism 2002 13 5-11.
5. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL & MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science 2000 289 950-953.
6. Christodoulides C, Laudes M, Cawthorn WP, Schinner S, Soos M, O'Rahilly S, Sethi JK & Vidal-Puig A. TheWnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. Journal of Cell Science 2006 119 2613-2620.
7. Heller RS, Klein T, Ling Z, Heimberg H, Katoh M, Madsen OD & Serup P. Expression of Wnt, frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expression 2003 11 141-147.
8. Schinner S, Ulgen F, Papewalis C, Schott M,Woelk A, Vidal-Puig A & Scherbaum WA. Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules. Diabetologia 2008 51 147-154.
9. Rulifson IC, Karnik SK, Heiser PW, Ten Berge D, Chen H, Gu X, Taketo MM, Nusse R, Hebrok M & Kim SK. Wnt signaling regulates pancreatic beta cell proliferation. PNAS 2007 104 6247-6252.
10. Hino S, Tanji C, Nakayama KI & Kikuchi A. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination. Molecular and Cellular Biology 2005 25 9063-9072.
11. Liu Z & Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. Journal of Biological Chemistry 2008 283 8723-8735.
12. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J & Maedler K. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 2008 57 645-653.
13. Fujino T, Asaba H, Kang MJ, Ikeda Y, Sone H, Takada S, Kim DH, Ioka RX, Ono M, Tomoyori H, Okubo M, Murase T, Kamataki A, Yamamoto J, Magoori K, Takahashi S, Miyamoto Y, Oishi H, Nose M, Okazaki M, Usui S, Imaizumi K, Yanagisawa M, Sakai J & Yamamoto TT. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. PNAS 2003 100 229-234.
14. Murtaugh LC, Law AC, Dor Y & Melton DA. Beta-catenin is essential for pancreatic acinar but not islet development. Development 2005 132 4663-4674.
15. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A & Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genetics 2006 38 320-323.
16. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM & Altshuler D. TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. New England Journal of Medicine 2006 355 241-250.
17. Cauchi S, El AY, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D & Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. Journal of Molecular Medicine 2007 85 777-782.
18. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, Balkau B, Charpentier G, Pattou F, Stetsyuk V, Scharfmann R, Staels B, Fruhbeck G & Froguel P. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006 55 2903-2908.
19. Hayashi T, Iwamoto Y, Kaku K, Hirose H & Maeda S. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia 2007 50 980-984.
20. Helgason A, Palsson S, Thorleifsson G, Grant SF, Emilsson V, Gunnarsdottir S, Adeyemo A, Chen Y, Chen G, Reynisdottir I, Benediktsson R, Hinney A, Hansen T, Andersen G, Borch-Johnsen K, Jorgensen T, Schafer H, Faruque M, Doumatey A, Zhou J,Wilensky RL, ReillyMP, Rader DJ, Bagger Y, Christiansen C, Sigurdsson G, Hebebrand J, Pedersen O, Thorsteinsdottir U, Gulcher JR, Kong A, Rotimi C & Stefansson K. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genetics 2007 39 218-225.
21. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S, Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC, Andersen G, Borch-Johnsen K, Jorgensen T, van Vliet-Ostaptchouk JV, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Rotimi C, Gurney M, Chan JC, Pedersen O, Sigurdsson G, Gulcher JR, Thorsteinsdottir U, Kong A & Stefansson K. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nature Genetics 2007 39 770-775.
22. Chang YC, Chang TJ, Jiang YD, Kuo SS, Lee KC, Chiu KC & Chuang LM. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes 2007 56 2631-2637.
23. Lyssenko V. The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update. Current Opinion in Clinical Nutrition and Metabolic Care 2008 11 385-392.
24. Florez JC. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 2008 51 1100-1110.
25. Jin T. The Wnt signalling pathway and diabetes mellitus. Diabetologia 2008 51 1771-1780.
26. Wegner L, Hussain MS, Pilgaard K, Hansen T, Pedersen O, Vaag A & Poulsen P. Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins. Clinics in Endocrinology and Metabolism 2008 93 4013-4019.
27. Yi F, Brubaker PL & Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. Journal of Biological Chemistry 2005 280 1457-1464.
28. Ni Z, Anini Y, Fang X, Mills G, Brubaker PL & Jin T. Transcriptional activation of the proglucagon gene by lithium and beta-catenin in intestinal endocrine L cells. Journal of Biological Chemistry 2003 278 1380-1387.
29. Schafer SA, Tschritter O, Machicao F, Thamer C, Stefan N, Gallwitz B, Holst JJ, Dekker JM, 't Hart LM, Nijpels G, van Haeften TW, Haring HU & Fritsche A. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 2007 50 2443-2450.
30. Lyssenko V, Lupi R, Marchetti P, Del GS, Orho-Melander M, Almgren P, Sjogren M, Ling C, Eriksson KF, Lethagen AL, Mancarella R, Berglund G, Tuomi T, Nilsson P, Del PS & Groop L. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. Journal of Clinical Investigation 2007 117 2155-2163.
31. Ross SE, Erickson RL, Gerin I, DeRose PM, Bajnok L, Longo KA, Misek DE, Kuick R, Hanash SM, Atkins KB, Andresen SM, Nebb HI, Madsen L, Kristiansen K & MacDougald OA. Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Molecular and Cellular Biology 2002 22 5989-5999.
32. Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, Lucas PC, Opp MR & MacDougald OA. Wnt10b inhibits development of white and brown adipose tissues. Journal of Biological Chemistry 2004 279 35503-35509.
33. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA & Bornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors. PNAS 2003 100 14211-14216.
34. Schinner S,Willenberg HS, Krause D, SchottM, Lamounier-Zepter V, Krug AW, Ehrhart-Bornstein M, Bornstein SR & Scherbaum WA. Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. International Journal of Obesity 2007 31 864-870.
35. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B & Shaughnessy JD Jr. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. New England Journal of Medicine 2003 349 2483-2494.
36. Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, Jan De Beur SM, Schiavi SC & Kumar R. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. Journal of Clinical Investigation 2003 112 785-794.
37. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathologica et Microbiologica Scandinavica. Section A 1978 86A 367-373.
38. Ulgen F, Scherbaum WA, Partke HJ, Bornstein SR & Schinner S. Intrapancreatic adipocyte deposition in a mouse model of the metabolic syndrome. Hormone and Metabolic Research 2008 40 507-509.
39. Etard C, Wedlich D, Bauer A, Huber O & Kuhl M. Expression of Xenopus homologs of the beta-catenin binding protein pontin 52. Mechanisms of Development 2000 94 219-222.
40. Eberhart CG & Argani P. Wnt signaling in human development: beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage. Pediatric and Developmental Pathology 2001 4 351-357.
41. Suwa T, Chen M, Hawks CL & Hornsby PJ. Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex. Journal of Endocrinology 2003 178 149-158.
42. Semba S, Kusumi R, Moriya T & Sasano H. Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocrine Pathology 2000 11 243-250.
43. Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagnere AM, Rene-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C & Bertherat J. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Research 2005 65 7622-7627.
44. Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA & Bourdeau I. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD). Clinical Endocrinology 2008 69 367-373.
45. Tadjine M, Lampron A, Ouadi L & Bourdeau I. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clinical Endocrinology 2008 68 264-270.
46. Blaker H, Sutter C, Kadmon M, Otto HF, Von Knebel-Doeberitz M, Gebert J & Helmke BM. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli, genes chromosomes. Cancer 2004 41 93-98.
47. Marchesa P, Fazio VW, Church JM & McGannon E. Adrenal masses in patients with familial adenomatous polyposis. Diseases of the Colon and Rectum 1997 40 1023-1028.
48. Smith TG, Clark SK, Katz DE, Reznek RH & Phillips RK. Adrenal masses are associated with familial adenomatous polyposis. Diseases of the Colon and Rectum 2000 43 1739-1742.
49. Gaujoux S, Tissier F, Groussin L, Libe R, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X & Bertherat J. Wnt/beta-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2008 93 4135-4140.
50. Chen M & Hornsby PJ. Adenovirus-delivered DKK3/Wnt4 and steroidogenesis in primary cultures of adrenocortical cells. Hormone and Metabolic Research 2006 38 549-555.
51. Heikkila M, Peltoketo H, Leppaluoto J, Ilves M, Vuolteenaho O & Vainio S. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 2002 143 4358-4365.
52. Kuulasmaa T, Jaaskelainen J, Suppola S, Pietilainen T, Heikkila P, Aaltomaa S, Kosma VM & Voutilainen R. Wnt-4 mRNA expression in human adrenocortical tumors and cultured adrenal cells. Hormone and Metabolic Research 2008 40 668-673.
53. Gummow BM, Winnay JN & Hammer GD. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. Journal of Biological Chemistry 2003 278 26572-26579.